Determination of the Origin of Charge Heterogeneity in a Murine Monoclonal Antibody

Pharmaceutical Research - Tập 17 Số 9 - Trang 1110-1117 - 2000
Perkins, Melissa1, Theiler, Rolf2, Lunte, Susan2, Jeschke, Margit2
1Department of Pharmaceutical Research, The University of Kansas, Lawrence
2Novartis Pharma AG, Biotechnology Development & Production, Basel, Switzerland

Tóm tắt

Purpose. The aim of this study was to elucidate the molecular basis of charge heterogeneity found in a purified monoclonal IgG1 antibody, MMA383. Methods. Cation exchange chromatography (CEX) and isoelectric focusing (IEF) were used to monitor charge heterogeneity. CEX in conjunction with carboxypeptidase B digests of the antibody was used to determine the contribution of C-terminal lysines to MMA383 charge heterogeneity. Potential chemical degradation sites were identified by peptide mapping of individual chains, with peptide identification by mass spectrometry (MALDI-TOF MS). Peptide sequencing was used to determine specific deamidation sites. Binding constants of predominant isoforms were compared by surface plasmon resonance (SPR). Results. Extensive charge heterogeneity of purified MMA383 was detected by CEX and IEF. Removal of C-terminal lysines simplified the IEF pattern to nine predominant isoforms. Quantitation of isoaspartate in each of the isoforms indicated deamidation of MMA383 as a major cause of charge heterogeneity. CEX of the individual isoform chains suggested the presence of one deamidation site on each of the heavy and light chains. The two sites of deamidation were identified using peptide mapping, sequencing and mass spectrometry. SPR results showed no significant difference in the binding parameters among the isoforms. Conclusions. C-terminal lysine microheterogeneity and deamidation of Asn141 in the heavy chain and Asn161 in the light chain are the major causes of MMA383 charge heterogeneity. Identification of the two deamidation sites will allow replacement of these amino acids in order to create a product less susceptible to degradation.

Từ khóa


Tài liệu tham khảo

citation_journal_title=Cancer Immunol. Immunother.; citation_title=Carbohydrate antigens as targets for active specific immunotherapy; citation_author=G. Ragupathi; citation_volume=43; citation_publication_date=1996; citation_pages=152-157; citation_id=CR1

citation_journal_title=Nat. Med.; citation_title=Treatment of advanced solid tumors with immunotoxin LMB-1: An antibody linked to Pseudomonas exotoxin; citation_author=L. H. Pai, R. Wittes, A. Setser, M. C. Willingham, I. Pastan; citation_volume=2; citation_publication_date=1996; citation_pages=350-353; citation_id=CR2

citation_journal_title=Sem. Cancer Biol.; citation_title=Anti-idiotypic monoclonal antibody cancer vaccines; citation_author=P. B. Chapman; citation_volume=6; citation_publication_date=1995; citation_pages=367-374; citation_id=CR3

citation_journal_title=Proc. Soc. Biol. Therapy; citation_title=A monoclonal antiidiotypic antibody that mimicks the Lewis Y carbohydrate antigen· Immunization of Rhesus monkeys leads to a strong immune response specific for Lewis Y positive cancer; citation_author=H. Loibner, H. Jaksche, E. Janzek; citation_volume=8; citation_publication_date=1995; citation_pages=66; citation_id=CR4

Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use. US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, February 28, 1997.

citation_journal_title=Biochem. J.; citation_title=A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins; citation_author=R. Jefferies, J. Lund, H. Mizutani, H. Nakagawa, Y. Kawazoe, Y. Arata, N. Takahashi; citation_volume=268; citation_publication_date=1990; citation_pages=529-537; citation_id=CR6

citation_journal_title=Chem. Immunol.; citation_title=Glycosylation of antibody molecules: Structural and functional significance; citation_author=R. Jefferis, J. Lund; citation_volume=65; citation_publication_date=1997; citation_pages=111-128; citation_id=CR7

citation_journal_title=Pharm. Res.; citation_title=Stability of protein pharmaceuticals; citation_author=M. Manning, K. Patel, R. Borchardt; citation_volume=6; citation_publication_date=1989; citation_pages=903-918; citation_id=CR8

citation_journal_title=Degradative covalent reactions important to protein stability; citation_author=D. B. Volkin, H. Mach, C. R. Middaugh; citation_volume=8; citation_publication_date=1997; citation_pages=105-22; citation_id=CR9

citation_title=Sequencing of Proteins and Peptides; citation_publication_date=1981; citation_id=CR10; citation_author=G. Allen; citation_publisher=North-Holland

citation_journal_title=J. Chromatogr. A.; citation_title=Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture; citation_author=R. J. Harris; citation_volume=705; citation_publication_date=1995; citation_pages=129-134; citation_id=CR11

citation_journal_title=Pharm. Res.; citation_title=Identification of sites of degradation in a therapeutic monoclonal antibody by peptide mapping; citation_author=D. Kroon, A. Baldwin-Ferro, P. Lalan; citation_volume=9; citation_publication_date=1992; citation_pages=1386-1393; citation_id=CR12

citation_title=Cleavage at Asn-Gly bonds with hydroxylamine; citation_inbook_title=Methods Enzymol. Vol. XLVII, Enzyme Structure; citation_publication_date=1977; citation_id=CR13; citation_author=P. Bornstein; citation_author=G. Balian; citation_publisher=Academic Press

citation_journal_title=J. Biol. Chem.; citation_title=Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins; citation_author=R. Stephenson, S. Clarke; citation_volume=264; citation_publication_date=1989; citation_pages=6164-6170; citation_id=CR14

citation_journal_title=J. Mol. Biol.; citation_title=Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal antilysozyme antibody D44.1; citation_author=B. C. Branden, H. Souchon, J.-L. Eisele, G. A. Bentley, T. N. Bhat, J. Navaza, R.J. Poljak; citation_volume=243; citation_publication_date=1994; citation_pages=767-781; citation_id=CR15

citation_journal_title=Int. J. Pept. Protein Res.; citation_title=Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins; citation_author=S. Clarke; citation_volume=30; citation_publication_date=1987; citation_pages=808-821; citation_id=CR16

citation_journal_title=Science; citation_title=Tertiary structure is a principal determinant to protein deamidation; citation_author=A. A. Kossiakoff; citation_volume=240; citation_publication_date=1988; citation_pages=191-194; citation_id=CR17

citation_journal_title=J. Biol. Chem.; citation_title=Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides; citation_author=R. Tyler-Cross, V. Schirch; citation_volume=266; citation_publication_date=1991; citation_pages=22549-22556; citation_id=CR18

citation_title=Lability of asparagine and aspartic acid residues in proteins and peptides, spontaneous deamidation and isomerization reactions; citation_inbook_title=Stability of Protein Pharmaceuticals, Part A, Chemical and Physical Pathways of Protein Degradation; citation_publication_date=1992; citation_pages=1-29; citation_id=CR19; citation_author=S. Clarke; citation_author=R. Stephenson; citation_author=J. Lowenson; citation_publisher=Plenum Press

citation_journal_title=Biochemistry; citation_title=β-Aspartyl Peptides in Enzymatic Hydrolysates of Protein; citation_author=E. Haley, B. Corcoran, F. Dorer, D. Buchanan; citation_volume=5; citation_publication_date=1966; citation_pages=3229-3235; citation_id=CR20

citation_journal_title=Science; citation_title=The mechanisms of irreversible enzyme inactivation at 100C; citation_author=T. J. Ahern, A. M. Klibanov; citation_volume=228; citation_publication_date=1985; citation_pages=1280-1284; citation_id=CR21

citation_journal_title=Biochemistry; citation_title=Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: Identification and effect on binding affinity; citation_author=J. Cacia, R. Keck, L.G. Presta, J. Frenz; citation_volume=35; citation_publication_date=1996; citation_pages=1897-903; citation_id=CR22

citation_journal_title=Protein Eng.; citation_title=Sequence and structure determinants of the nonenzymic deamidation of asparagine and glutamine residues in proteins; citation_author=H. T. Wright; citation_volume=4; citation_publication_date=1991; citation_pages=283-294; citation_id=CR23

citation_journal_title=Immunochemistry; citation_title=Released myelin basic protein: The immunogenic factor?; citation_author=F. C. Westall; citation_volume=11; citation_publication_date=1974; citation_pages=513-515; citation_id=CR24

Thông tin
Thông tin xuất bản

Pharmaceutical Research

Tập 17 Số 9

1110-1117

Thông tin tác giả